Defense World
05 Apr 2026, 08:50 UTC · 30w ago
Michael Hoffman Acquires 713,800 Shares of Annovis Bio (NYSE:ANVS) Stock
Impact · against what's priced in
Annovis Bio (ANVS) sees a positive signal from significant insider buying by Director Michael Hoffman, though this is tempered by a recent earnings miss. The insider sales at Astera Labs (ALAB) and Nuvalent (NUVL) are minor relative to overall holdings and lack material impact.
- ANVS+0.30
No priced-in read yet





